e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of captopril on the IL
10
serum levels in experimental pulmonary fibrosis
M. B. B. Ben Brahim, S. M. Maalej, L. G. Gharbi, B. S. Soltani, S. Y. Yaalaoui, F. T. Tritar, S. B. K. Ben Khamsa (Tunis, Tunisia)
Source:
Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session:
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session type:
Thematic Poster Session
Number:
823
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. B. B. Ben Brahim, S. M. Maalej, L. G. Gharbi, B. S. Soltani, S. Y. Yaalaoui, F. T. Tritar, S. B. K. Ben Khamsa (Tunis, Tunisia). Impact of captopril on the IL
10
serum levels in experimental pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 823
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Correlation of HRCT proven inflammatory changes with serum levels of ACE, sIL-2r and calciuria in pulmonary sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003
Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Leptin and adiponectin levels in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Effect of curcumin on inflammation in experimental pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation?
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009
Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Correlation of serum levels of matrix-metalloproteinase-9, cyclo-oxygenase-2, and prostaglandin-E-2 in Chronic obstructive pulmonary disease(COPD)
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Effect of bosentan on MMP-7 levels as add-on therapy in idiopathic pulmonary fibrosis. A prospective study
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept